ストックスクリーナーアプリを入手
65.39
0.88%
0.405
前日終値:
$64.98
開ける：
$64.74
24時間の取引高:
1.24M
Relative Volume:
0.10
時価総額：
$82.59B
収益：
$372.81B
当期純損益:
$4.61B
株価収益率:
17.86
EPS:
3.66
ネットキャッシュフロー:
$6.33B
1週間 パフォーマンス:
-0.60%
1か月 パフォーマンス:
+3.69%
6か月 パフォーマンス:
+13.95%
1年 パフォーマンス:
-12.84%
1日の値動き範囲:
$64.44
$66.33
1週間の範囲:
$64.00
$67.09
52週間の値動き範囲:
$43.56
$80.75
Cvs Health Corp Stock (CVS) Company Profile
CVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
65.35 | 82.59B | 372.81B | 4.61B | 6.33B | 3.66 |
|
UNH
Unitedhealth Group Inc
|
482.93 | 445.31B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
419.32 | 93.88B | 176.81B | 5.98B | 4.55B | 25.61 |
|
CI
Cigna Group
|
309.81 | 84.48B | 244.38B | 3.43B | 8.96B | 12.24 |
|
HUM
Humana Inc
|
252.10 | 30.13B | 117.76B | 1.21B | 2.39B | 9.95 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-13 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | アップグレード | Edward Jones | Hold → Buy |
| 2024-12-03 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-11-18 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | アップグレード | Barclays | Equal Weight → Overweight |
| 2024-10-04 | アップグレード | TD Cowen | Hold → Buy |
| 2024-05-30 | 開始されました | Robert W. Baird | Neutral |
| 2024-05-07 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-05-02 | ダウングレード | UBS | Buy → Neutral |
| 2024-05-01 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2023-12-22 | 開始されました | HSBC Securities | Buy |
| 2023-09-19 | アップグレード | Evercore ISI | In-line → Outperform |
| 2023-09-12 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | ダウングレード | Edward Jones | Buy → Hold |
| 2023-05-26 | 開始されました | Piper Sandler | Overweight |
| 2023-04-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-01-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-11-23 | 再開されました | Morgan Stanley | Overweight |
| 2022-06-17 | 開始されました | Loop Capital | Buy |
| 2022-05-27 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-02-11 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | 開始されました | Goldman | Buy |
| 2021-12-01 | 開始されました | Seaport Research Partners | Buy |
| 2021-05-19 | 開始されました | Wells Fargo | Equal Weight |
| 2021-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-01-08 | アップグレード | Jefferies | Hold → Buy |
| 2020-09-17 | 開始されました | Piper Sandler | Overweight |
| 2020-07-01 | 開始されました | SVB Leerink | Mkt Perform |
| 2020-05-14 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | 再開されました | RBC Capital Mkts | Outperform |
| 2019-09-12 | 開始されました | Deutsche Bank | Buy |
| 2019-06-05 | アップグレード | Standpoint Research | Hold → Buy |
| 2019-04-29 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | 開始されました | Guggenheim | Buy |
| 2019-04-15 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-04-10 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-13 | 開始されました | Bernstein | Outperform |
| 2019-02-20 | ダウングレード | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2018-12-18 | 開始されました | Barclays | Overweight |
| 2018-11-29 | 再開されました | Goldman | Neutral |
| 2018-11-28 | 開始されました | Evercore ISI | Outperform |
| 2018-10-26 | 再開されました | Wolfe Research | Peer Perform |
| 2018-07-09 | アップグレード | Citigroup | Neutral → Buy |
| 2018-02-27 | 再開されました | BofA/Merrill | Buy |
| 2018-02-13 | 繰り返されました | Citigroup | Neutral |
すべてを表示
Cvs Health Corp (CVS) 最新ニュース
CVS Health Co. (NYSE:CVS) Shares Sold by Moors & Cabot Inc. - MarketBeat
AGF Management Ltd. Sells 106,468 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Daiwa Securities Group Inc. Acquires 11,955 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Johnson Investment Counsel Inc. Sells 8,307 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Ashton Thomas Private Wealth LLC Has $349,000 Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Callan Family Office LLC Purchases New Shares in CVS Health Co. (NYSE:CVS) - MarketBeat
Banco Santander S.A. Trims Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Victory Capital Management Inc. Has $47.63 Million Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Stock Soars 47% YTD: Is Digital Growth Fueling a Buy Opportunity? - Nasdaq
Candriam S.C.A. Acquires 13,040 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Raymond James Financial Inc. Buys New Shares in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Corporation (CVS): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now - Insider Monkey
CVS opens smaller format stores as industry sees big shift - Fox Business
PNC Financial Services Group Inc. Sells 144,567 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Sowell Financial Services LLC Grows Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
M&T Bank Corp Trims Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS PBM Caused Up To $330M In Part D Damages, Judge Told - Law360
Is CVS Health (CVS) the Best Stock to Buy Right Now? - Insider Monkey
CVS is opening smaller stores that only have pharmacies - ABC7 Bay Area
CVS Health Will Ditch Retail Sales at New Pharmacy Locations - Markets Insider
CVS plans to open at least 12 pharmacy-only stores in U.S. - Providence Business News
CVS to open new kind of pharmacy store within the next year for parts of US - NBC Chicago
CVS Health (NYSE:CVS) shareholders have endured a 30% loss from investing in the stock three years ago - Yahoo Canada Finance
CVS Health’s Strategic Initiatives and Profitability Potential Drive Buy Rating - TipRanks
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
Roberts Glore & Co. Inc. IL Reduces Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Plans Chain of Smaller-Footprint Pharmacy-Focused Stores - PYMNTS.com
Personal CFO Solutions LLC Has $450,000 Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health (CVS): Buy, Sell, Or Hold Post Q4 Earnings? - Barchart
CVS Health Co. (NYSE:CVS) Stock Holdings Decreased by Steward Partners Investment Advisory LLC - MarketBeat
CVS Health Co. (NYSE:CVS) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
SBI Securities Co. Ltd. Purchases New Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Assetmark Inc. Has $17.33 Million Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Keybank National Association OH Lowers Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
Is CVS Health Corporation (CVS) the Top Health Insurance Stock to Buy Now? - MSN
‘A life saved’: Virginia woman credits fast-acting CVS pharmacy staff for saving her life - AOL
CVS Health Co. (NYSE:CVS) Shares Sold by CM Management LLC - MarketBeat
HM Payson & Co. Sells 12,119 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Atlantic Union Bankshares Corp - MarketBeat
Davis Selected Advisers Has $511.12 Million Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
AMF Tjanstepension AB Increases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
Cullen Frost Bankers Inc. Has $277,000 Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Atria Investments Inc Cuts Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Schechter Investment Advisors LLC - MarketBeat
Seizert Capital Partners LLC Purchases 105,708 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Inceptionr LLC Acquires New Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Clark Estates Inc. NY Grows Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Top 10 Health Insurance Stocks To Buy - Insider Monkey
Cvs health SVP James Clark sells shares for $498,487 - Investing.com
Is CVS Health Stock Outperforming the S&P 500? - Nasdaq
Aetna Investor Appeals Decision Tossing Suit Over CVS Deal (1) - Bloomberg Tax
Cvs Health Corp (CVS) 財務データ
収益
当期純利益
現金流量
EPS
2.32%
0.08%
大文字化:
|
ボリューム (24 時間):